At 22x trailing earnings but just 4x forward earnings with a PEG of 0.8, the market is clearly discounting either a sharp earnings normalization or material risk ahead. The valuation spread between current P/E and Forward P/E signals expectations of a major earnings inflection, yet the Altman Z-Score of 0 is an outright balance sheet distress warning that cannot be ignored. Price/Book at 0.6 and Price/Sales at 1.3 suggest asset-level undervaluation, but the combination of 0.00% ROE and a razor-thin 1.20% operating margin indicates weak profitability quality. This is a statistically cheap stock with balance sheet stress signals embedded in the price—potentially mispriced, but only for investors comfortable underwriting real financial risk.